Pivot Pharmaceuticals Inc. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-4) (Filed With SEC on May 3, 2019)
- 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-3) (Filed With SEC on May 3, 2019)
- Royalty Agreement between our company and AquaBrew Inc. dated March 1, 2018 (Filed With SEC on March 12, 2018)
- BINDING LETTER OF INTENT TECHNOLOGY LICENSING AGREEMENT (Filed With SEC on December 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- DEBT FORGIVENESS AGREEMENT (Filed With SEC on September 15, 2017)
- Licensing Agreement between our company and Altum Pharmaceuticals Inc. dated September 12, 2017 (Filed With SEC on September 13, 2017)
- SCHEDULE A JOB DESCRIPTION (Filed With SEC on April 29, 2016)
- SCHEDULE A JOB DESCRIPTION (Filed With SEC on April 29, 2016)
- DIRECTOR'S AGREEMENT (Filed With SEC on December 15, 2015)
- DIRECTOR'S AGREEMENT (Filed With SEC on December 15, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- DIRECTORS AGREEMENT (Filed With SEC on March 26, 2015)
- Director and Option Agreement with Dr. Maziar Badii dated July 13, 2009 (Filed With SEC on August 7, 2009)
- Director and Option Agreement with Dr. Kamran Shojania dated July 13, 2009 (Filed With SEC on August 7, 2009)